Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Do we Know which Patients with the Antiphospholipid Syndrome Should Receive Long-term High Dose Anti-coagulation?. Local targets link to admitted publications; unresolved targets remain external evidence.
Syndrome of the black swan
10.1093/rheumatology/26.5.324 · 1987 · External reference
Clinical manifestations and management of the antiphospholipid syndrome
10.1177/096120339600500217 · 1996 · External reference
The ‘primary’ antiphospholipid syndrome: major clinical and serological features
10.1097/00005792-198911000-00004 · 1989 · External reference
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop
10.1002/1529-0131(199907)42:7<1309::aid-anr1>3.0.co;2-f · 1999 · External reference
Antiphospholipid antibodies and venous thromboembolism
10.1182/blood.v86.10.3685.bloodjournal86103685 · 1995 · External reference
Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound
10.1001/archinte.1993.00410240085010 · 1993 · External reference
Pulmonary embolism
10.1056/nejm199807093390207 · 1998 · External reference
A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients
10.1056/nejm199311043291901 · 1993 · External reference
Deep venous thrombosis and the risk of pulmonary embolism. A systematic study
1992 · External reference
Management of venous thromboembolism
10.1056/nejm199612123352407 · 1996 · External reference
The clinical course of pulmonary embolism
10.1056/nejm199205073261902 · 1992 · External reference
The long-term clinical course of acute deep venous thrombosis
10.7326/0003-4819-125-1-199607010-00001 · 1996 · External reference
Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis
10.1055/s-0038-1657492 · 1997 · External reference
Venous thrombosis as a chronic disease
10.1056/nejm199903253401209 · 1999 · External reference
A comparison of 6 weeks with 6 months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group
10.1056/nejm199506223322501 · 1995 · External reference
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group
10.1056/nejm199702063360601 · 1997 · External reference
Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia
10.1001/archinte.1997.00440400024003 · 1997 · External reference
Oral anticoagulant therapy for venous thromboembolism
10.1056/nejm199702063360608 · 1997 · External reference
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
10.1001/archinte.1993.00410130073007 · 1993 · External reference
Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group
10.7326/0003-4819-118-7-199304010-00005 · 1993 · External reference
Antiplatelet therapy: new foundations for optimal treatment decisions
1999 · External reference
Antithrombotic and thrombolytic therapy for ischemic stroke
10.1378/chest.114.5_supplement.683s · 1998 · External reference
Anticoagulant treatment in stroke prevention
1999 · External reference
A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
10.1002/ana.410420606 · 1997 · External reference
The feasibility of a collaborative double-blind study using an anticoagulant
10.1159/000108175 · 1997 · External reference
Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?
10.1016/s0248-8663(99)83089-6 · 1999 · External reference
Answers to the anti-phospholipid-antibody syndrome?
10.1056/nejm199504133321510 · 1995 · External reference
The management of thrombosis in the antiphospholipid-antibody syndrome
10.1056/nejm199504133321504 · 1995 · External reference
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients
10.7326/0003-4819-117-4-303 · 1992 · External reference
Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment
10.1136/ard.52.9.689 · 1993 · External reference
Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration
10.1136/bmj.309.6963.1215 · 1994 · External reference
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
10.1056/nejm199903253401201 · 1999 · External reference
Hemorrhagic complications of long-term anticoagulant therapy in seven patients with systemic lupus erythematosus and antiphospholipid syndrome
1997 · External reference
Anticardiolipin antibodies and recurrent thromboembolism
10.1055/s-0038-1655939 · 1997 · External reference
Antiphospholipid antibodies recurrent thromboembolism, and intensity of warfarin anticoagulation
10.1055/s-0038-1650380 · 1996 · External reference
Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group
10.1016/s0002-9343(98)00060-6 · 1998 · External reference
The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus
10.1055/s-0037-1614324 · 1999 · External reference
IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study
10.1161/01.str.28.9.1660 · 1997 · External reference
Cerebrovascular ischemic events with high positive anticardiolipin antibodies
10.1161/01.str.29.11.2245 · 1998 · External reference
Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options
10.1002/ana.410370712 · 1995 · External reference
High prevalence of significant heart valve lesions in patients with the ‘primary’ antiphospholipid syndrome
10.1177/096120339100100108 · 1991 · External reference
